Andrew G Gianoukakis, MD

Andrew G. Gianoukakis, MD

Investigator, The Lundquist Institute
Professor of Medicine, David Geffen School of Medicine at UCLA
Program Director Endocrinology Fellowship Program
Chief, Division of Endocrinology, Diabetes and Metabolism, Harbor-UCLA Medical Center

Autoimmune thyroid disease, Thyroid dysfunction, Thyroid cancer

Research Description

Dr. Gianoukakis is a Professor of Medicine; he joined the Internal Medicine faculty in 2002. Dr. Gianoukakis is the Program Director of The Harbor-UCLA Endocrinology Fellowship Program and Chief of the Division of Endocrinology as well as APDEM past president (Association of Program Directors in Endocrinology and Metabolism). His special interest focuses on autoimmune thyroid disease, thyroid dysfunction and thyroid cancer. Dr. Gianoukakis is investigating molecular markers as a diagnostic tool in the Thyroid cancer. Dr. Gianoukakis is a member of ITOG (International Thyroid Oncology Group) and SCThyCC (Southern California Thyroid Cancer Consortium) and a Principal Investigator of clinical trials investigating the utility of small molecule kinase inhibitors for the treatment of advanced thyroid cancer.
Research Interests


  • MD, 1993, University of Patras, School of Health Sciences, Patras, Greece

Recent and/or Significant Publications

All Publications authored or coauthored by Andrew G. Gianoukakis, MD on


Dr. Andrew Gianoukakis Discusses Thyroid cancer on Innovations In Medicine